SG11202106794WA - Method for treating lower back pain - Google Patents

Method for treating lower back pain

Info

Publication number
SG11202106794WA
SG11202106794WA SG11202106794WA SG11202106794WA SG11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA
Authority
SG
Singapore
Prior art keywords
lower back
back pain
treating lower
treating
pain
Prior art date
Application number
SG11202106794WA
Inventor
Silviu Itescu
Roger Brown
Original Assignee
Mesoblast Int Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Int Sarl filed Critical Mesoblast Int Sarl
Publication of SG11202106794WA publication Critical patent/SG11202106794WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202106794WA 2019-01-02 2020-01-02 Method for treating lower back pain SG11202106794WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962787654P 2019-01-02 2019-01-02
PCT/IB2020/050015 WO2020141473A1 (en) 2019-01-02 2020-01-02 Method for treating lower back pain

Publications (1)

Publication Number Publication Date
SG11202106794WA true SG11202106794WA (en) 2021-07-29

Family

ID=69185652

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202106794WA SG11202106794WA (en) 2019-01-02 2020-01-02 Method for treating lower back pain

Country Status (10)

Country Link
US (1) US20220143097A1 (en)
EP (1) EP3906035A1 (en)
JP (1) JP2022515916A (en)
KR (1) KR20210110835A (en)
CN (1) CN113631173A (en)
AU (1) AU2020204805A1 (en)
BR (1) BR112021013158A2 (en)
CA (1) CA3125308A1 (en)
SG (1) SG11202106794WA (en)
WO (1) WO2020141473A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX348735B (en) 2006-01-13 2017-06-27 Mesoblast Int Sarl MESENCHYMAL STEM CELLS EXPRESSING TNF-a RECEPTOR.
CN112402365B (en) * 2020-10-26 2023-10-03 山东博森医学工程技术有限公司 PRP gel-loaded umbilical cord mesenchymal stem cell composition for treating intervertebral disc degeneration diseases
AU2022210364A1 (en) * 2021-01-22 2023-08-31 Mesoblast International Sàrl Opioid sparing compositions and methods of using the same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593089A (en) 1980-07-30 1986-06-03 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluorescein aminoglycosides
US4751190A (en) 1985-07-22 1988-06-14 Abbott Laboratories Fluorescence polarization immunoassay and reagents for use therein
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
WO1992001070A1 (en) 1990-07-09 1992-01-23 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
AU663725B2 (en) 1991-08-20 1995-10-19 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Adenovirus mediated transfer of genes to the gastrointestinal tract
DE4211351A1 (en) 1992-04-04 1993-10-07 Behringwerke Ag Method for analyzing particle-enhanced agglutination reactions on centrifugal analyzers by determining the turbidity brightening
CN1127527A (en) 1993-05-17 1996-07-24 加利福尼亚大学董事会 Ribozyme gene therapy for HIV infection and Aids
US6541213B1 (en) 1996-03-29 2003-04-01 University Of Washington Microscale diffusion immunoassay
CA2244326C (en) 1997-08-11 2006-03-28 Shinichi Eda Microparticle enhanced light scattering agglutination assay and microparticle reagents therefor
US6566051B1 (en) 1999-01-15 2003-05-20 Medtox Scientific, Inc. Lateral flow test strip
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
CA2457930C (en) 2001-08-20 2012-06-19 Proteome Systems Intellectual Property Pty Ltd. Diagnostic testing process and apparatus
JP2006507510A (en) 2002-11-21 2006-03-02 インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Fluid markers for tissue hypoxia
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
CN1893962A (en) * 2003-11-13 2007-01-10 德普伊斯派尔公司 Autologous treatment of degenerated disc with cells
US8367405B2 (en) 2005-04-12 2013-02-05 Mesoblast, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
WO2007136673A2 (en) * 2006-05-19 2007-11-29 Medistem Laboratories, Inc. Treatment of disc degenerative disease and compositions for same
ES2872337T3 (en) * 2008-06-25 2021-11-02 Mesoblast Inc STRO-1bright cells for use in the treatment of low back pain
KR20230140604A (en) * 2015-05-05 2023-10-06 메조블라스트 인터내셔널 에스에이알엘 Potency assay
US20180021380A1 (en) * 2016-07-21 2018-01-25 Sungkwang Medical Foundation Composition including mesenchymal stem cell derived from adipose tissues and hyaluronic acid derivative, method of preparing the same, and method of preventing or treating low back pain using the same
US20180344899A1 (en) * 2017-06-01 2018-12-06 Creative Medical Technologies, Inc. Enhancement of nucleus pulposus regeneration by enhanced perfusion of perispinal area by combination drug, gene and cellular therapies

Also Published As

Publication number Publication date
AU2020204805A1 (en) 2021-07-29
KR20210110835A (en) 2021-09-09
US20220143097A1 (en) 2022-05-12
CN113631173A (en) 2021-11-09
WO2020141473A1 (en) 2020-07-09
BR112021013158A2 (en) 2021-09-14
EP3906035A1 (en) 2021-11-10
CA3125308A1 (en) 2020-07-09
JP2022515916A (en) 2022-02-22

Similar Documents

Publication Publication Date Title
IL285496A (en) Methods for treating cholestasis
IL279748A (en) Composition and method for treating pain
IL289301A (en) Stimulation apparatus
IL288201A (en) Apparatus for treating teeth
EP4041374A4 (en) Stimulation apparatus
IL280128A (en) Method for treating epilepsy
IL287907A (en) Methods for treating cancer
SG11202106794WA (en) Method for treating lower back pain
IL285847A (en) Methods for treating map3k8 positive cancers
IL281792A (en) Treatment methods
IL291565A (en) Methods for treating hyperphenylalaninemia
IL288937A (en) Improved treatment using eyp001
IL290770A (en) Compounds and methods for treating oxalate-related diseases
IL281839A (en) Treatment methods
FI3897994T3 (en) Method and arrangement for process water treatment
IL284629A (en) Methods for treating ocular surface pain
ZA202007920B (en) Laser treatment method
SG11202111960PA (en) Method for treating endometriosis-associated pain by using diaminopyrimidine compound
ZA202001927B (en) Method for treating tnf alpha-related diseases
IL268111A (en) Methods of treating pain
EP4051214A4 (en) Method for treating skin
CA195803S (en) Skin treatment apparatus
EP4058063A4 (en) Methods for treating diseases
ZA202101302B (en) Hair treatment method
GB201907065D0 (en) Surface treatment method